Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2004

View Archived Issues

Organic nitrate prodrug RS-7897 shows improved pharmacological properties in dogs

ARC-111, a novel topoisomerase I antitumor candidate

Use of beta-blockers reduces fracture risk

Vanilloid agonists effective in detrusor hyperreflexia

Snail venom peptide CGX-1051 reduces infarction in rabbit models

Ro-1151240 in stress urinary incontinence

Novel glucocorticoid receptor modulators designed at Boehringer Ingelheim

GSK scientists develop novel dual ACE/NEP inhibitors

Phase III data for a fixed travoprost/timolol combination in glaucoma

New alpha7 nAchR agonists with utility in cognitive disorders claimed by Bayer

New IKK inhibitors and their use described by Boehringer Ingelheim scientists

Lipid profile changes found with pioglitazone and metformin in obese patients with type 2 diabetes

Wyeth team presents new guanidine-based 5-HT6 ligands

Selective or dual GSK-3/PKC inhibitors prepared and tested at Janssen

Different phototoxicity profiles found with fluoroquinolone antibiotics in healthy subjects

New antidiabetic glycogen phosphorylase inhibitors under study at Aventis

International health teams gear up for potential flu pandemic

Improved pregnancy rates found with Menopur in women undergoing IVF

Approval for Provigil expanded label

Niaspan completes European mutual recognition procedure

First European named patient sales of Voraxaze

SuperGen completes rolling NDA for Orathecin

AZD-3582 recommended for further development based on phase II results

Aventis rejects Sanofi-Synthelabo's offer

Immtech receives initial payment from MMV for DB-289 development

GenoMed launches common cold trial using ACE approach

Genta clarifies Genasense agreement terms

Esperion updates 2003 progress of four products in clinical development

Amgen reports Q4 and year-end 2003 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...